Nancy Thornberry
Director at Denali Therapeutics Inc. (DNLI)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $262K
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Sep 4SEC | DNLIDenali Therapeutics Inc. | Sell Plan | 10,82420,301 held (−35%) | $22.85 | $247K | -22.9% |
| Sep 4SEC | DNLIDenali Therapeutics Inc. | Sell Plan | 61519,686 held (−3%) | $23.74 | $15K | -25.8% |
- Sell
Director Nancy Thornberry sold $247K of DNLI at $22.85 — cuts the stake by 35%; pre-scheduled 10b5-1 plan sale.
- Sell
Director Nancy Thornberry sold $15K of DNLI at $23.74 — pre-scheduled 10b5-1 plan sale.